227 related articles for article (PubMed ID: 29623548)
1. Nanomedicine for obesity treatment.
Zhang Y; Yu J; Qiang L; Gu Z
Sci China Life Sci; 2018 Apr; 61(4):373-379. PubMed ID: 29623548
[TBL] [Abstract][Full Text] [Related]
2. Drug treatment of obesity: established and emerging therapies.
Isidro ML; Cordido F
Mini Rev Med Chem; 2009 Jun; 9(6):664-73. PubMed ID: 19519492
[TBL] [Abstract][Full Text] [Related]
3. [The pharmacotherapy of obesity].
Budai KA; Mirzahosseini A; Noszál Béla ; Tóth G
Acta Pharm Hung; 2015; 85(1):3-17. PubMed ID: 26137782
[TBL] [Abstract][Full Text] [Related]
4. Emerging pharmacological approaches to the treatment of obesity.
Wasan KM; Looije NA
J Pharm Pharm Sci; 2005 Aug; 8(2):259-71. PubMed ID: 16124937
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy for childhood obesity: present and future prospects.
Sherafat-Kazemzadeh R; Yanovski SZ; Yanovski JA
Int J Obes (Lond); 2013 Jan; 37(1):1-15. PubMed ID: 22929210
[TBL] [Abstract][Full Text] [Related]
6. Anti-obesity drugs: a critical review of current therapies and future opportunities.
Clapham JC; Arch JR; Tadayyon M
Pharmacol Ther; 2001 Jan; 89(1):81-121. PubMed ID: 11316515
[TBL] [Abstract][Full Text] [Related]
7. Treating obesity: pharmacology of energy expenditure.
Clapham JC
Curr Drug Targets; 2004 Apr; 5(3):309-23. PubMed ID: 15058315
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy of obesity: emerging drugs and targets.
Chakrabarti R
Expert Opin Ther Targets; 2009 Feb; 13(2):195-207. PubMed ID: 19236237
[TBL] [Abstract][Full Text] [Related]
9. Phytochemicals in regulating fatty acid β-oxidation: Potential underlying mechanisms and their involvement in obesity and weight loss.
Rupasinghe HP; Sekhon-Loodu S; Mantso T; Panayiotidis MI
Pharmacol Ther; 2016 Sep; 165():153-63. PubMed ID: 27288729
[TBL] [Abstract][Full Text] [Related]
10. Natural Products with Anti-obesity Effects and Different Mechanisms of Action.
Fu C; Jiang Y; Guo J; Su Z
J Agric Food Chem; 2016 Dec; 64(51):9571-9585. PubMed ID: 27931098
[TBL] [Abstract][Full Text] [Related]
11. Natural Dietary and Herbal Products in Anti-Obesity Treatment.
Sun NN; Wu TY; Chau CF
Molecules; 2016 Oct; 21(10):. PubMed ID: 27727194
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy of obesity.
Hofbauer KG; Nicholson JR
Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):475-84. PubMed ID: 17115344
[TBL] [Abstract][Full Text] [Related]
13. Strategies for Browning Agent Delivery.
Zhang W; Sheng T; Gu Z; Zhang Y
Pharm Res; 2021 Aug; 38(8):1327-1334. PubMed ID: 34398404
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
15. Emerging drugs for obesity therapy.
Zanella MT; Ribeiro Filho FF
Arq Bras Endocrinol Metabol; 2009 Mar; 53(2):271-80. PubMed ID: 19466220
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy of obesity: an update.
Schurgin S; Siegel RD
Nutr Clin Care; 2003; 6(1):27-37. PubMed ID: 12841428
[TBL] [Abstract][Full Text] [Related]
17. Locally Induced Adipose Tissue Browning by Microneedle Patch for Obesity Treatment.
Zhang Y; Liu Q; Yu J; Yu S; Wang J; Qiang L; Gu Z
ACS Nano; 2017 Sep; 11(9):9223-9230. PubMed ID: 28914527
[TBL] [Abstract][Full Text] [Related]
18. Obesity pharmacotherapy: current perspectives and future directions.
Misra M
Curr Cardiol Rev; 2013 Feb; 9(1):33-54. PubMed ID: 23092275
[TBL] [Abstract][Full Text] [Related]
19. Anti-obesity drugs: use, mechanisms and clinical importance.
Adam O; Forth W
Int J Clin Pharmacol Ther; 2001 Jun; 39(6):232-8. PubMed ID: 11430630
[TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapy of Obesity: Limits and Perspectives.
Rosa-Gonçalves P; Majerowicz D
Am J Cardiovasc Drugs; 2019 Aug; 19(4):349-364. PubMed ID: 30793263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
